Reunion Neuroscience Announces Participation in Premiere Maternal Mental Health Event
Patient Enrollment Ongoing in Reunion's Phase 2, 35 Site RECONNECT Study in Postpartum Depression (PPD)
MORRISTOWN, N.J., March 04, 2025 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation psychedelic-inspired therapeutic solutions, today announced its participation in The Policy Center for Maternal Mental Health's 2025 Maternal Mental Health (MMH) FORUM, taking place March 18-19, 2025.
'We are honored to participate in this forum as a featured panel presenter. Our partnership with the Policy Center for Maternal Mental Health reflects our belief in the importance of improving awareness of maternal mental health disorders – which impact up to 1 in 5 expecting and postpartum mothers in the United States – and in ensuring screening, diagnosis and treatment is standardized across the health delivery system,' said Greg Mayes, President and Chief Executive Officer of Reunion Neuroscience. 'The MMH FORUM provides a much-needed venue for policymakers, payors and provider leaders to discuss solutions for closing the gaps in maternal mental health care, and we look forward to presenting on RE104 and our ongoing RECONNECT Phase 2 trial, as we work to deliver a potentially new approach to treating postpartum depression, which may offer mothers safe, fast-acting and effective relief.'
The RECONNECT Phase 2 clinical trial (NCT06342310), a multicenter, randomized, double-blind, active dose-controlled clinical trial is evaluating the safety and efficacy of a single subcutaneous dose of RE104 in adult female patients with moderate-to-severe PPD. To learn more about the study and eligibility for enrollment, please visit www.ppdreconnectstudy.com.
'Novel treatment solutions like RE-104, the psychedelic treatment being developed and studied by Reunion Neuroscience, are critical to closing gaps in mental health care and offering patients a range of effective treatments,' said Joy Burkhard, Chief Executive Officer of The Policy Center for Maternal Mental Health. 'Both The Policy Center for Maternal Mental Health and Reunion Neuroscience are committed to advancing policies that expand access to care, ensuring every mother receives timely and effective mental health support.'
Presentation at the 2025 Maternal Mental Health (MMH) FORUM
Reunion's President and Chief Executive Officer, Greg Mayes, will present on RE104 and the RECONNECT Phase 2 clinical trial as part of a panel discussion, 'New Treatment Options,' at the 2025 Maternal Mental Health FORUM taking place virtually March 18-19, 2025. Details of the panel presentation are as follows:
Time: 2:30 p.m. ET
About RE104
The Company's lead product candidate, RE104, is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT. Reunion designed RE104 to deliver a short duration psychedelic experience compared to longer duration psychedelics like psilocybin. In a Phase 1 clinical trial, RE104 produced a psychedelic state similar in intensity and quality to psilocybin, but lasting only about half the time (3-4 hours), while demonstrating a similar, favorable safety profile. RE104 is currently being evaluated in the RECONNECT Phase 2 ( NCT06342310) clinical trial, a multicenter, randomized, double-blind, active dose-controlled clinical trial in moderate-to-severe postpartum depression (PPD) patients. Reunion plans to initiate the REKINDLE Phase 2 clinical trial, a randomized, double-blind, parallel-group, dose-controlled trial in adjustment disorder (AjD) in cancer and other medical illnesses.
About RECONNECT
The RECONNECT Phase 2 clinical trial ( NCT06342310), a multicenter, randomized, double-blind, active dose-controlled clinical trial, is evaluating the safety and efficacy of a single subcutaneous dose of RE104 in adult female patients with moderate-to-severe PPD. To learn more about the study and eligibility for enrollment, please visit www.ppdreconnectstudy.com.
About Reunion Neuroscience Inc.
Reunion Neuroscience is a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation psychedelic therapeutic solutions. In August of 2023, Reunion Neuroscience became a private company and in May 2024, the Company completed a Series A financing co-led by MPM BioImpact and Novo Holdings. Reunion is actively investigating the use of its lead product candidate, RE104, in postpartum depression and adjustment disorder, as well as in additional neuropsychiatric indications where there remains a significant unmet need that is not addressed by the current standard of care. For more information about the company, visit https://reunionneuro.com.
The Policy Center for Maternal Mental Health is a non-profit think tank providing data and insights as well as cross-sector policy and practice solutions to prevent the suffering of mothers, babies, and families associated with untreated maternal mental health disorders, like postpartum depression. For more information, visit www.PolicyCenterMMH.org and follow @PolicyCenterMMH on LinkedIn and X.
Hannah Deresiewicz
Precision AQ
PR Inquiries:
Ashley Murphy
Precision AQ
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
3 days ago
Stargazers dazzled as spirals of light appear in night sky
Stargazers on the lookout for the Perseid meteor shower were treated to an extra nighttime spectacular on Tuesday night as spirals appeared in the sky along the East Coast. The unusual light show -- which appeared to show circling lights in the heavens -- was on display after multiple rocket launches. Videos began circulating online in several states, including Maryland, New York, New Jersey, Tennessee, Illinois, Ohio and Nebraska, after 9 p.m. ET Tuesday, social media posts show. ABC Philadelphia station WPVI began receiving calls and messages from viewers around 10:30 p.m. to report the phenomenon, the station reported. The spiraling lights seemed to appear "out of nowhere," Blake Brown, who witnessed the dazzling display from Algonquin, Illinois, while watching for the meteor shower, told ABC News. The majority of the spiraling light sightings likely stemmed from the launch of Ariane 6, said Jonathan C. McDowell, an astrophysicist for the Harvard-Smithsonian Center for Astrophysics. That rocket lifted off from the Guiana Space Centre at Europe's Spaceport in Kourou, French Guiana, at about 8:37 p.m. ET, according to Eumetsat, a European operational satellite agency for monitoring weather. Ariane 6, about 196-feet tall, has the ability to launch both heavy and light payloads for applications such as Earth observation, telecommunication, meteorology, science and navigation, according to the European Space Agency. The appearance of the spirals in the sky was likely the result of the upper stage of the rocket tumbling as it underwent a disposal rocket firing at the end of the launch, McDowell told ABC News. The spiral light occurs when reflection from sunlight interacts with the frozen plume of fuel from the exhaust of rockets. "It's a nice, perfect spiral because it's way out in space with no air to distort the shape," McDowell said. Tuesday's launch, which brought a weather satellite to orbit, is the third-ever mission for the powerful rocket, according to Another rocket, the Vulcan Centaur Rocket, successfully lifted off from the Cape Canaveral Space Force Station in Florida at 8:56 p.m. ET, according to the United Launch Alliance. The 202-foot rocket was carrying a pair of experimental navigation satellites on behalf of the United States Space Force's first-ever mission, according to "The Vulcan launched east and went to a high orbit, and was still coasting upward [without the rocket firing] when the spiral was seen," McDowell said. "If people in Florida saw something at 9:37, 9:45 pm ET, that could have been the Vulcan."
Fox Sports
3 days ago
- Fox Sports
Cowboys Owner Jerry Jones Reveals Cancer Diagnosis, Credits Experimental Drug
National Football League Cowboys Owner Jerry Jones Reveals Cancer Diagnosis, Credits Experimental Drug Published Aug. 13, 2025 5:53 p.m. ET share facebook x reddit link Dallas Cowboys owner Jerry Jones credited an experimental trial drug for successfully treating advanced melanoma as he disclosed his cancer diagnosis publicly for the first time. Jones revealed his illness in a documentary, "America's Team: The Gambler and His Cowboys," which will debut on Netflix next week. The 82-year-old Jones then told The Dallas Morning News how he was initially diagnosed in June 2010 and underwent two surgeries on his lung and two on his lymph nodes over the next 10 years after skin cancer cells metastasized to other parts of his body. "I was saved by a fabulous treatment and great doctors and a real miracle (drug) called PD-1 (therapy)," Jones said. "I went into trials for that PD-1, and it has been one of the great medicines. I now have no tumors." First-year Cowboys head coach Brian Schottenheimer described Jones' fight with cancer as an "amazing story" and praised him for going public. "I'm glad that Jerry shared it, just because I think it gives people hope," Schottenheimer said Wednesday. "It gives people the strength to say, 'OK,' you know, 'Hey, you can beat this.'" ADVERTISEMENT Schottenheimer, 51, used his last news conference of the Cowboys' nearly monthlong stay in Southern California to talk about his own cancer diagnosis. He underwent surgery in 2003 for thyroid cancer at the Mayo Clinic in Rochester, Minnesota. Then-Washington Commanders owner Dan Snyder helped arrange Schottenheimer's treatment two years after firing his father, Marty Schottenheimer, as head coach. Brian Schottenheimer was Washington's quarterbacks coach during the 2001 season, the same year Snyder himself was treated for thyroid cancer. "It doesn't discriminate against anybody," Schottenheimer said. "And mine was certainly less serious, but I was 28 when I was diagnosed with thyroid cancer. Nothing like Stage 4, nothing like what Jerry and other people have to go through. But you hear that word 'cancer,' and it scares the hell out of you." Reporting by The Associated Press. Want great stories delivered right to your inbox? Create or log in to your FOX Sports account, and follow leagues, teams and players to receive a personalized newsletter daily! FOLLOW Follow your favorites to personalize your FOX Sports experience National Football League Dallas Cowboys What did you think of this story? share
Newsweek
3 days ago
- Newsweek
Alien: Earth Episode 3 – Release Date, Schedule, How To Watch
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Entertainment gossip and news from Newsweek's network of contributors Alien: Earth crashed onto FX and Hulu last night with episodes one and two, but with tensions rising between rival corporations and secrets now revealed, you're probably wanting to know: where is episode three of Alien: Earth? The series may have premiered with two episodes, but the rest of this season will drop weekly on Tuesdays at 5 pm PT/8 pm ET. Sydney Chandler as Wendy in FX's Alien: Earth. Sydney Chandler as Wendy in FX's Alien: Earth. FX Networks To help you navigate the release, we've got all the information on how to watch Alien: Earth episode three, including Alien: Earth episode three release time and Alien: Earth episode three release date. Alien: Earth Episode 3 Release Date Alien: Earth episode three releases August 19, 2025. New episodes of Alien: Earth air weekly on Tuesdays through September 23, 2025. Alien: Earth Episode 3 – How to Watch Alien: Earth episode three will be available to watch on FX and stream on Hulu from 5 pm Pacific Time (PT) on August 19, 2025/8 pm Eastern Time (ET). To watch Alien: Earth, you will need a Hulu subscription. A monthly subscription is $9.99, or you can get the Disney Bundle, which includes Hulu, Disney+, and either ESPN+ or Max. That starts at $16.99 per month. What Time Does Alien: Earth Episode 3 Come Out? Alien: Earth episode three will be released at 5 pm Pacific Time on August 19/8 pm Eastern Time. New episodes of Alien: Earth debut at different times depending on your time zone due to the late PT release. Here's what time new episodes become available globally: August 19 BRT: 9:00 am August 20 BST : 1:00 am : 1:00 am CEST : 2:00 am : 2:00 am IST : 5:30 am : 5:30 am JST : 9:00 am : 9:00 am AET : 10:00 am : 10:00 am NZST: 12:00 pm Will There Be 2 Episodes of Alien: Earth This Week? No. Episode three will drop on its own on August 19, and new episodes will release weekly through September 23. Alien: Earth Release Schedule Episode One: August 12 August 12 Episode Two: August 12 August 12 Episode Three: August 19 August 19 Episode Four: August 26 August 26 Episode Five: September 2 September 2 Episode Six: September 9 September 9 Episode Seven: September 16 September 16 Episode Eight: September 23 Alien: Earth Episode 3 Runtime The official runtime for episode three of Alien: Earth is currently unknown. What Will Happen in Alien: Earth Episode 3? The official synopsis for Alien: Earth episode one reads: The team returns home with unexpected cargo. An unsettling experiment occurs, and a new talent is discovered. The episode is titled "Metamorphosis". Synopses for upcoming episodes of Alien: Earth are as follows: Episode One: When a spaceship crash-lands on Earth, a sister searches for her brother amidst an unexpected alien threat. When a spaceship crash-lands on Earth, a sister searches for her brother amidst an unexpected alien threat. Episode Two: Tensions rise between rival corporations, a reunion takes place, and a secret is revealed. Tensions rise between rival corporations, a reunion takes place, and a secret is revealed. Episode Three: The team returns home with unexpected cargo. An unsettling experiment occurs, and a new talent is discovered. The team returns home with unexpected cargo. An unsettling experiment occurs, and a new talent is discovered. Episode Four: An unexpected connection is formed while a covert plot puts everyone in danger. An unexpected connection is formed while a covert plot puts everyone in danger. Episode Five: An outer-space vessel in peril leads to a dangerous reckoning. An outer-space vessel in peril leads to a dangerous reckoning. Episode Six: TBC TBC Episode Seven: TBC TBC Episode Eight: TBC (as per IMDb) Will There Be a Season 2 of Alien: Earth? It has not yet been confirmed whether or not Alien: Earth will return for a season two.
